Global Pneumococcal Vaccination Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
LPI (LP Information)' newest research report, the “Pneumococcal Vaccination Industry Forecast” looks at past sales and reviews total world Pneumococcal Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected Pneumococcal Vaccination sales for 2023 through 2029. With Pneumococcal Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pneumococcal Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Pneumococcal Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pneumococcal Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pneumococcal Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pneumococcal Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pneumococcal Vaccination.
The global Pneumococcal Vaccination market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pneumococcal Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pneumococcal Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pneumococcal Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pneumococcal Vaccination players cover Pfizer, GSK, MSD, Sanofipasteur, CDIBP, WALVAX, Sinovac and Bio Kangtai, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccination market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pneumococcal Vaccination market?
What factors are driving Pneumococcal Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pneumococcal Vaccination market opportunities vary by end market size?
How does Pneumococcal Vaccination break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Pneumococcal Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria.
LPI (LP Information)' newest research report, the “Pneumococcal Vaccination Industry Forecast” looks at past sales and reviews total world Pneumococcal Vaccination sales in 2022, providing a comprehensive analysis by region and market sector of projected Pneumococcal Vaccination sales for 2023 through 2029. With Pneumococcal Vaccination sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pneumococcal Vaccination industry.
This Insight Report provides a comprehensive analysis of the global Pneumococcal Vaccination landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pneumococcal Vaccination portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pneumococcal Vaccination market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pneumococcal Vaccination and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pneumococcal Vaccination.
The global Pneumococcal Vaccination market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pneumococcal Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pneumococcal Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pneumococcal Vaccination is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pneumococcal Vaccination players cover Pfizer, GSK, MSD, Sanofipasteur, CDIBP, WALVAX, Sinovac and Bio Kangtai, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pneumococcal Vaccination market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- PPSV 23
- PCV 7/13
- PCV 10
- Child
- Adult
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Pfizer
- GSK
- MSD
- Sanofipasteur
- CDIBP
- WALVAX
- Sinovac
- Bio Kangtai
What is the 10-year outlook for the global Pneumococcal Vaccination market?
What factors are driving Pneumococcal Vaccination market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pneumococcal Vaccination market opportunities vary by end market size?
How does Pneumococcal Vaccination break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pneumococcal Vaccination Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pneumococcal Vaccination by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pneumococcal Vaccination by Country/Region, 2018, 2022 & 2029
2.2 Pneumococcal Vaccination Segment by Type
2.2.1 PPSV
2.2.2 PCV 7/13
2.2.3 PCV
2.3 Pneumococcal Vaccination Sales by Type
2.3.1 Global Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
2.3.2 Global Pneumococcal Vaccination Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pneumococcal Vaccination Sale Price by Type (2018-2023)
2.4 Pneumococcal Vaccination Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Vaccination Sales by Application
2.5.1 Global Pneumococcal Vaccination Sale Market Share by Application (2018-2023)
2.5.2 Global Pneumococcal Vaccination Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pneumococcal Vaccination Sale Price by Application (2018-2023)
3 GLOBAL PNEUMOCOCCAL VACCINATION BY COMPANY
3.1 Global Pneumococcal Vaccination Breakdown Data by Company
3.1.1 Global Pneumococcal Vaccination Annual Sales by Company (2018-2023)
3.1.2 Global Pneumococcal Vaccination Sales Market Share by Company (2018-2023)
3.2 Global Pneumococcal Vaccination Annual Revenue by Company (2018-2023)
3.2.1 Global Pneumococcal Vaccination Revenue by Company (2018-2023)
3.2.2 Global Pneumococcal Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global Pneumococcal Vaccination Sale Price by Company
3.4 Key Manufacturers Pneumococcal Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pneumococcal Vaccination Product Location Distribution
3.4.2 Players Pneumococcal Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PNEUMOCOCCAL VACCINATION BY GEOGRAPHIC REGION
4.1 World Historic Pneumococcal Vaccination Market Size by Geographic Region (2018-2023)
4.1.1 Global Pneumococcal Vaccination Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pneumococcal Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pneumococcal Vaccination Market Size by Country/Region (2018-2023)
4.2.1 Global Pneumococcal Vaccination Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pneumococcal Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pneumococcal Vaccination Sales Growth
4.4 APAC Pneumococcal Vaccination Sales Growth
4.5 Europe Pneumococcal Vaccination Sales Growth
4.6 Middle East & Africa Pneumococcal Vaccination Sales Growth
5 AMERICAS
5.1 Americas Pneumococcal Vaccination Sales by Country
5.1.1 Americas Pneumococcal Vaccination Sales by Country (2018-2023)
5.1.2 Americas Pneumococcal Vaccination Revenue by Country (2018-2023)
5.2 Americas Pneumococcal Vaccination Sales by Type
5.3 Americas Pneumococcal Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pneumococcal Vaccination Sales by Region
6.1.1 APAC Pneumococcal Vaccination Sales by Region (2018-2023)
6.1.2 APAC Pneumococcal Vaccination Revenue by Region (2018-2023)
6.2 APAC Pneumococcal Vaccination Sales by Type
6.3 APAC Pneumococcal Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pneumococcal Vaccination by Country
7.1.1 Europe Pneumococcal Vaccination Sales by Country (2018-2023)
7.1.2 Europe Pneumococcal Vaccination Revenue by Country (2018-2023)
7.2 Europe Pneumococcal Vaccination Sales by Type
7.3 Europe Pneumococcal Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pneumococcal Vaccination by Country
8.1.1 Middle East & Africa Pneumococcal Vaccination Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pneumococcal Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa Pneumococcal Vaccination Sales by Type
8.3 Middle East & Africa Pneumococcal Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pneumococcal Vaccination
10.3 Manufacturing Process Analysis of Pneumococcal Vaccination
10.4 Industry Chain Structure of Pneumococcal Vaccination
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pneumococcal Vaccination Distributors
11.3 Pneumococcal Vaccination Customer
12 WORLD FORECAST REVIEW FOR PNEUMOCOCCAL VACCINATION BY GEOGRAPHIC REGION
12.1 Global Pneumococcal Vaccination Market Size Forecast by Region
12.1.1 Global Pneumococcal Vaccination Forecast by Region (2024-2029)
12.1.2 Global Pneumococcal Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pneumococcal Vaccination Forecast by Type
12.7 Global Pneumococcal Vaccination Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Pneumococcal Vaccination Product Portfolios and Specifications
13.1.3 Pfizer Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pneumococcal Vaccination Product Portfolios and Specifications
13.2.3 GSK Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 MSD
13.3.1 MSD Company Information
13.3.2 MSD Pneumococcal Vaccination Product Portfolios and Specifications
13.3.3 MSD Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 MSD Main Business Overview
13.3.5 MSD Latest Developments
13.4 Sanofipasteur
13.4.1 Sanofipasteur Company Information
13.4.2 Sanofipasteur Pneumococcal Vaccination Product Portfolios and Specifications
13.4.3 Sanofipasteur Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sanofipasteur Main Business Overview
13.4.5 Sanofipasteur Latest Developments
13.5 CDIBP
13.5.1 CDIBP Company Information
13.5.2 CDIBP Pneumococcal Vaccination Product Portfolios and Specifications
13.5.3 CDIBP Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CDIBP Main Business Overview
13.5.5 CDIBP Latest Developments
13.6 WALVAX
13.6.1 WALVAX Company Information
13.6.2 WALVAX Pneumococcal Vaccination Product Portfolios and Specifications
13.6.3 WALVAX Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 WALVAX Main Business Overview
13.6.5 WALVAX Latest Developments
13.7 Sinovac
13.7.1 Sinovac Company Information
13.7.2 Sinovac Pneumococcal Vaccination Product Portfolios and Specifications
13.7.3 Sinovac Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sinovac Main Business Overview
13.7.5 Sinovac Latest Developments
13.8 Bio Kangtai
13.8.1 Bio Kangtai Company Information
13.8.2 Bio Kangtai Pneumococcal Vaccination Product Portfolios and Specifications
13.8.3 Bio Kangtai Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bio Kangtai Main Business Overview
13.8.5 Bio Kangtai Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pneumococcal Vaccination Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pneumococcal Vaccination by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pneumococcal Vaccination by Country/Region, 2018, 2022 & 2029
2.2 Pneumococcal Vaccination Segment by Type
2.2.1 PPSV
2.2.2 PCV 7/13
2.2.3 PCV
2.3 Pneumococcal Vaccination Sales by Type
2.3.1 Global Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
2.3.2 Global Pneumococcal Vaccination Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pneumococcal Vaccination Sale Price by Type (2018-2023)
2.4 Pneumococcal Vaccination Segment by Application
2.4.1 Child
2.4.2 Adult
2.5 Pneumococcal Vaccination Sales by Application
2.5.1 Global Pneumococcal Vaccination Sale Market Share by Application (2018-2023)
2.5.2 Global Pneumococcal Vaccination Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pneumococcal Vaccination Sale Price by Application (2018-2023)
3 GLOBAL PNEUMOCOCCAL VACCINATION BY COMPANY
3.1 Global Pneumococcal Vaccination Breakdown Data by Company
3.1.1 Global Pneumococcal Vaccination Annual Sales by Company (2018-2023)
3.1.2 Global Pneumococcal Vaccination Sales Market Share by Company (2018-2023)
3.2 Global Pneumococcal Vaccination Annual Revenue by Company (2018-2023)
3.2.1 Global Pneumococcal Vaccination Revenue by Company (2018-2023)
3.2.2 Global Pneumococcal Vaccination Revenue Market Share by Company (2018-2023)
3.3 Global Pneumococcal Vaccination Sale Price by Company
3.4 Key Manufacturers Pneumococcal Vaccination Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pneumococcal Vaccination Product Location Distribution
3.4.2 Players Pneumococcal Vaccination Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PNEUMOCOCCAL VACCINATION BY GEOGRAPHIC REGION
4.1 World Historic Pneumococcal Vaccination Market Size by Geographic Region (2018-2023)
4.1.1 Global Pneumococcal Vaccination Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pneumococcal Vaccination Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pneumococcal Vaccination Market Size by Country/Region (2018-2023)
4.2.1 Global Pneumococcal Vaccination Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pneumococcal Vaccination Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pneumococcal Vaccination Sales Growth
4.4 APAC Pneumococcal Vaccination Sales Growth
4.5 Europe Pneumococcal Vaccination Sales Growth
4.6 Middle East & Africa Pneumococcal Vaccination Sales Growth
5 AMERICAS
5.1 Americas Pneumococcal Vaccination Sales by Country
5.1.1 Americas Pneumococcal Vaccination Sales by Country (2018-2023)
5.1.2 Americas Pneumococcal Vaccination Revenue by Country (2018-2023)
5.2 Americas Pneumococcal Vaccination Sales by Type
5.3 Americas Pneumococcal Vaccination Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pneumococcal Vaccination Sales by Region
6.1.1 APAC Pneumococcal Vaccination Sales by Region (2018-2023)
6.1.2 APAC Pneumococcal Vaccination Revenue by Region (2018-2023)
6.2 APAC Pneumococcal Vaccination Sales by Type
6.3 APAC Pneumococcal Vaccination Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pneumococcal Vaccination by Country
7.1.1 Europe Pneumococcal Vaccination Sales by Country (2018-2023)
7.1.2 Europe Pneumococcal Vaccination Revenue by Country (2018-2023)
7.2 Europe Pneumococcal Vaccination Sales by Type
7.3 Europe Pneumococcal Vaccination Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pneumococcal Vaccination by Country
8.1.1 Middle East & Africa Pneumococcal Vaccination Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pneumococcal Vaccination Revenue by Country (2018-2023)
8.2 Middle East & Africa Pneumococcal Vaccination Sales by Type
8.3 Middle East & Africa Pneumococcal Vaccination Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pneumococcal Vaccination
10.3 Manufacturing Process Analysis of Pneumococcal Vaccination
10.4 Industry Chain Structure of Pneumococcal Vaccination
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pneumococcal Vaccination Distributors
11.3 Pneumococcal Vaccination Customer
12 WORLD FORECAST REVIEW FOR PNEUMOCOCCAL VACCINATION BY GEOGRAPHIC REGION
12.1 Global Pneumococcal Vaccination Market Size Forecast by Region
12.1.1 Global Pneumococcal Vaccination Forecast by Region (2024-2029)
12.1.2 Global Pneumococcal Vaccination Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pneumococcal Vaccination Forecast by Type
12.7 Global Pneumococcal Vaccination Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Pneumococcal Vaccination Product Portfolios and Specifications
13.1.3 Pfizer Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 GSK
13.2.1 GSK Company Information
13.2.2 GSK Pneumococcal Vaccination Product Portfolios and Specifications
13.2.3 GSK Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 GSK Main Business Overview
13.2.5 GSK Latest Developments
13.3 MSD
13.3.1 MSD Company Information
13.3.2 MSD Pneumococcal Vaccination Product Portfolios and Specifications
13.3.3 MSD Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 MSD Main Business Overview
13.3.5 MSD Latest Developments
13.4 Sanofipasteur
13.4.1 Sanofipasteur Company Information
13.4.2 Sanofipasteur Pneumococcal Vaccination Product Portfolios and Specifications
13.4.3 Sanofipasteur Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Sanofipasteur Main Business Overview
13.4.5 Sanofipasteur Latest Developments
13.5 CDIBP
13.5.1 CDIBP Company Information
13.5.2 CDIBP Pneumococcal Vaccination Product Portfolios and Specifications
13.5.3 CDIBP Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 CDIBP Main Business Overview
13.5.5 CDIBP Latest Developments
13.6 WALVAX
13.6.1 WALVAX Company Information
13.6.2 WALVAX Pneumococcal Vaccination Product Portfolios and Specifications
13.6.3 WALVAX Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 WALVAX Main Business Overview
13.6.5 WALVAX Latest Developments
13.7 Sinovac
13.7.1 Sinovac Company Information
13.7.2 Sinovac Pneumococcal Vaccination Product Portfolios and Specifications
13.7.3 Sinovac Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Sinovac Main Business Overview
13.7.5 Sinovac Latest Developments
13.8 Bio Kangtai
13.8.1 Bio Kangtai Company Information
13.8.2 Bio Kangtai Pneumococcal Vaccination Product Portfolios and Specifications
13.8.3 Bio Kangtai Pneumococcal Vaccination Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Bio Kangtai Main Business Overview
13.8.5 Bio Kangtai Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pneumococcal Vaccination Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pneumococcal Vaccination Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of PPSV 23
Table 4. Major Players of PCV 7/13
Table 5. Major Players of PCV 10
Table 6. Global Pneumococcal Vaccination Sales by Type (2018-2023) & (Units)
Table 7. Global Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
Table 8. Global Pneumococcal Vaccination Revenue by Type (2018-2023) & ($ million)
Table 9. Global Pneumococcal Vaccination Revenue Market Share by Type (2018-2023)
Table 10. Global Pneumococcal Vaccination Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Pneumococcal Vaccination Sales by Application (2018-2023) & (Units)
Table 12. Global Pneumococcal Vaccination Sales Market Share by Application (2018-2023)
Table 13. Global Pneumococcal Vaccination Revenue by Application (2018-2023)
Table 14. Global Pneumococcal Vaccination Revenue Market Share by Application (2018-2023)
Table 15. Global Pneumococcal Vaccination Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Pneumococcal Vaccination Sales by Company (2018-2023) & (Units)
Table 17. Global Pneumococcal Vaccination Sales Market Share by Company (2018-2023)
Table 18. Global Pneumococcal Vaccination Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Pneumococcal Vaccination Revenue Market Share by Company (2018-2023)
Table 20. Global Pneumococcal Vaccination Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Pneumococcal Vaccination Producing Area Distribution and Sales Area
Table 22. Players Pneumococcal Vaccination Products Offered
Table 23. Pneumococcal Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pneumococcal Vaccination Sales by Geographic Region (2018-2023) & (Units)
Table 27. Global Pneumococcal Vaccination Sales Market Share Geographic Region (2018-2023)
Table 28. Global Pneumococcal Vaccination Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Pneumococcal Vaccination Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Pneumococcal Vaccination Sales by Country/Region (2018-2023) & (Units)
Table 31. Global Pneumococcal Vaccination Sales Market Share by Country/Region (2018-2023)
Table 32. Global Pneumococcal Vaccination Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Pneumococcal Vaccination Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Pneumococcal Vaccination Sales by Country (2018-2023) & (Units)
Table 35. Americas Pneumococcal Vaccination Sales Market Share by Country (2018-2023)
Table 36. Americas Pneumococcal Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Pneumococcal Vaccination Revenue Market Share by Country (2018-2023)
Table 38. Americas Pneumococcal Vaccination Sales by Type (2018-2023) & (Units)
Table 39. Americas Pneumococcal Vaccination Sales by Application (2018-2023) & (Units)
Table 40. APAC Pneumococcal Vaccination Sales by Region (2018-2023) & (Units)
Table 41. APAC Pneumococcal Vaccination Sales Market Share by Region (2018-2023)
Table 42. APAC Pneumococcal Vaccination Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Pneumococcal Vaccination Revenue Market Share by Region (2018-2023)
Table 44. APAC Pneumococcal Vaccination Sales by Type (2018-2023) & (Units)
Table 45. APAC Pneumococcal Vaccination Sales by Application (2018-2023) & (Units)
Table 46. Europe Pneumococcal Vaccination Sales by Country (2018-2023) & (Units)
Table 47. Europe Pneumococcal Vaccination Sales Market Share by Country (2018-2023)
Table 48. Europe Pneumococcal Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Pneumococcal Vaccination Revenue Market Share by Country (2018-2023)
Table 50. Europe Pneumococcal Vaccination Sales by Type (2018-2023) & (Units)
Table 51. Europe Pneumococcal Vaccination Sales by Application (2018-2023) & (Units)
Table 52. Middle East & Africa Pneumococcal Vaccination Sales by Country (2018-2023) & (Units)
Table 53. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Pneumococcal Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Pneumococcal Vaccination Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pneumococcal Vaccination Sales by Type (2018-2023) & (Units)
Table 57. Middle East & Africa Pneumococcal Vaccination Sales by Application (2018-2023) & (Units)
Table 58. Key Market Drivers & Growth Opportunities of Pneumococcal Vaccination
Table 59. Key Market Challenges & Risks of Pneumococcal Vaccination
Table 60. Key Industry Trends of Pneumococcal Vaccination
Table 61. Pneumococcal Vaccination Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pneumococcal Vaccination Distributors List
Table 64. Pneumococcal Vaccination Customer List
Table 65. Global Pneumococcal Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 66. Global Pneumococcal Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Pneumococcal Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 68. Americas Pneumococcal Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Pneumococcal Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 70. APAC Pneumococcal Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Pneumococcal Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 72. Europe Pneumococcal Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Pneumococcal Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 74. Middle East & Africa Pneumococcal Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Pneumococcal Vaccination Sales Forecast by Type (2024-2029) & (Units)
Table 76. Global Pneumococcal Vaccination Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Pneumococcal Vaccination Sales Forecast by Application (2024-2029) & (Units)
Table 78. Global Pneumococcal Vaccination Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Pneumococcal Vaccination Product Portfolios and Specifications
Table 81. Pfizer Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. GSK Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK Pneumococcal Vaccination Product Portfolios and Specifications
Table 86. GSK Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. MSD Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 90. MSD Pneumococcal Vaccination Product Portfolios and Specifications
Table 91. MSD Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. MSD Main Business
Table 93. MSD Latest Developments
Table 94. Sanofipasteur Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofipasteur Pneumococcal Vaccination Product Portfolios and Specifications
Table 96. Sanofipasteur Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Sanofipasteur Main Business
Table 98. Sanofipasteur Latest Developments
Table 99. CDIBP Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 100. CDIBP Pneumococcal Vaccination Product Portfolios and Specifications
Table 101. CDIBP Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. CDIBP Main Business
Table 103. CDIBP Latest Developments
Table 104. WALVAX Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 105. WALVAX Pneumococcal Vaccination Product Portfolios and Specifications
Table 106. WALVAX Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. WALVAX Main Business
Table 108. WALVAX Latest Developments
Table 109. Sinovac Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 110. Sinovac Pneumococcal Vaccination Product Portfolios and Specifications
Table 111. Sinovac Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Sinovac Main Business
Table 113. Sinovac Latest Developments
Table 114. Bio Kangtai Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 115. Bio Kangtai Pneumococcal Vaccination Product Portfolios and Specifications
Table 116. Bio Kangtai Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Bio Kangtai Main Business
Table 118. Bio Kangtai Latest Developments
Table 1. Pneumococcal Vaccination Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pneumococcal Vaccination Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of PPSV 23
Table 4. Major Players of PCV 7/13
Table 5. Major Players of PCV 10
Table 6. Global Pneumococcal Vaccination Sales by Type (2018-2023) & (Units)
Table 7. Global Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
Table 8. Global Pneumococcal Vaccination Revenue by Type (2018-2023) & ($ million)
Table 9. Global Pneumococcal Vaccination Revenue Market Share by Type (2018-2023)
Table 10. Global Pneumococcal Vaccination Sale Price by Type (2018-2023) & (US$/Unit)
Table 11. Global Pneumococcal Vaccination Sales by Application (2018-2023) & (Units)
Table 12. Global Pneumococcal Vaccination Sales Market Share by Application (2018-2023)
Table 13. Global Pneumococcal Vaccination Revenue by Application (2018-2023)
Table 14. Global Pneumococcal Vaccination Revenue Market Share by Application (2018-2023)
Table 15. Global Pneumococcal Vaccination Sale Price by Application (2018-2023) & (US$/Unit)
Table 16. Global Pneumococcal Vaccination Sales by Company (2018-2023) & (Units)
Table 17. Global Pneumococcal Vaccination Sales Market Share by Company (2018-2023)
Table 18. Global Pneumococcal Vaccination Revenue by Company (2018-2023) ($ Millions)
Table 19. Global Pneumococcal Vaccination Revenue Market Share by Company (2018-2023)
Table 20. Global Pneumococcal Vaccination Sale Price by Company (2018-2023) & (US$/Unit)
Table 21. Key Manufacturers Pneumococcal Vaccination Producing Area Distribution and Sales Area
Table 22. Players Pneumococcal Vaccination Products Offered
Table 23. Pneumococcal Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Pneumococcal Vaccination Sales by Geographic Region (2018-2023) & (Units)
Table 27. Global Pneumococcal Vaccination Sales Market Share Geographic Region (2018-2023)
Table 28. Global Pneumococcal Vaccination Revenue by Geographic Region (2018-2023) & ($ millions)
Table 29. Global Pneumococcal Vaccination Revenue Market Share by Geographic Region (2018-2023)
Table 30. Global Pneumococcal Vaccination Sales by Country/Region (2018-2023) & (Units)
Table 31. Global Pneumococcal Vaccination Sales Market Share by Country/Region (2018-2023)
Table 32. Global Pneumococcal Vaccination Revenue by Country/Region (2018-2023) & ($ millions)
Table 33. Global Pneumococcal Vaccination Revenue Market Share by Country/Region (2018-2023)
Table 34. Americas Pneumococcal Vaccination Sales by Country (2018-2023) & (Units)
Table 35. Americas Pneumococcal Vaccination Sales Market Share by Country (2018-2023)
Table 36. Americas Pneumococcal Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 37. Americas Pneumococcal Vaccination Revenue Market Share by Country (2018-2023)
Table 38. Americas Pneumococcal Vaccination Sales by Type (2018-2023) & (Units)
Table 39. Americas Pneumococcal Vaccination Sales by Application (2018-2023) & (Units)
Table 40. APAC Pneumococcal Vaccination Sales by Region (2018-2023) & (Units)
Table 41. APAC Pneumococcal Vaccination Sales Market Share by Region (2018-2023)
Table 42. APAC Pneumococcal Vaccination Revenue by Region (2018-2023) & ($ Millions)
Table 43. APAC Pneumococcal Vaccination Revenue Market Share by Region (2018-2023)
Table 44. APAC Pneumococcal Vaccination Sales by Type (2018-2023) & (Units)
Table 45. APAC Pneumococcal Vaccination Sales by Application (2018-2023) & (Units)
Table 46. Europe Pneumococcal Vaccination Sales by Country (2018-2023) & (Units)
Table 47. Europe Pneumococcal Vaccination Sales Market Share by Country (2018-2023)
Table 48. Europe Pneumococcal Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 49. Europe Pneumococcal Vaccination Revenue Market Share by Country (2018-2023)
Table 50. Europe Pneumococcal Vaccination Sales by Type (2018-2023) & (Units)
Table 51. Europe Pneumococcal Vaccination Sales by Application (2018-2023) & (Units)
Table 52. Middle East & Africa Pneumococcal Vaccination Sales by Country (2018-2023) & (Units)
Table 53. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Country (2018-2023)
Table 54. Middle East & Africa Pneumococcal Vaccination Revenue by Country (2018-2023) & ($ Millions)
Table 55. Middle East & Africa Pneumococcal Vaccination Revenue Market Share by Country (2018-2023)
Table 56. Middle East & Africa Pneumococcal Vaccination Sales by Type (2018-2023) & (Units)
Table 57. Middle East & Africa Pneumococcal Vaccination Sales by Application (2018-2023) & (Units)
Table 58. Key Market Drivers & Growth Opportunities of Pneumococcal Vaccination
Table 59. Key Market Challenges & Risks of Pneumococcal Vaccination
Table 60. Key Industry Trends of Pneumococcal Vaccination
Table 61. Pneumococcal Vaccination Raw Material
Table 62. Key Suppliers of Raw Materials
Table 63. Pneumococcal Vaccination Distributors List
Table 64. Pneumococcal Vaccination Customer List
Table 65. Global Pneumococcal Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 66. Global Pneumococcal Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 67. Americas Pneumococcal Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 68. Americas Pneumococcal Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 69. APAC Pneumococcal Vaccination Sales Forecast by Region (2024-2029) & (Units)
Table 70. APAC Pneumococcal Vaccination Revenue Forecast by Region (2024-2029) & ($ millions)
Table 71. Europe Pneumococcal Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 72. Europe Pneumococcal Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 73. Middle East & Africa Pneumococcal Vaccination Sales Forecast by Country (2024-2029) & (Units)
Table 74. Middle East & Africa Pneumococcal Vaccination Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Global Pneumococcal Vaccination Sales Forecast by Type (2024-2029) & (Units)
Table 76. Global Pneumococcal Vaccination Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 77. Global Pneumococcal Vaccination Sales Forecast by Application (2024-2029) & (Units)
Table 78. Global Pneumococcal Vaccination Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 79. Pfizer Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 80. Pfizer Pneumococcal Vaccination Product Portfolios and Specifications
Table 81. Pfizer Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 82. Pfizer Main Business
Table 83. Pfizer Latest Developments
Table 84. GSK Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 85. GSK Pneumococcal Vaccination Product Portfolios and Specifications
Table 86. GSK Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 87. GSK Main Business
Table 88. GSK Latest Developments
Table 89. MSD Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 90. MSD Pneumococcal Vaccination Product Portfolios and Specifications
Table 91. MSD Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 92. MSD Main Business
Table 93. MSD Latest Developments
Table 94. Sanofipasteur Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 95. Sanofipasteur Pneumococcal Vaccination Product Portfolios and Specifications
Table 96. Sanofipasteur Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 97. Sanofipasteur Main Business
Table 98. Sanofipasteur Latest Developments
Table 99. CDIBP Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 100. CDIBP Pneumococcal Vaccination Product Portfolios and Specifications
Table 101. CDIBP Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 102. CDIBP Main Business
Table 103. CDIBP Latest Developments
Table 104. WALVAX Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 105. WALVAX Pneumococcal Vaccination Product Portfolios and Specifications
Table 106. WALVAX Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 107. WALVAX Main Business
Table 108. WALVAX Latest Developments
Table 109. Sinovac Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 110. Sinovac Pneumococcal Vaccination Product Portfolios and Specifications
Table 111. Sinovac Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 112. Sinovac Main Business
Table 113. Sinovac Latest Developments
Table 114. Bio Kangtai Basic Information, Pneumococcal Vaccination Manufacturing Base, Sales Area and Its Competitors
Table 115. Bio Kangtai Pneumococcal Vaccination Product Portfolios and Specifications
Table 116. Bio Kangtai Pneumococcal Vaccination Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 117. Bio Kangtai Main Business
Table 118. Bio Kangtai Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pneumococcal Vaccination
Figure 2. Pneumococcal Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pneumococcal Vaccination Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Pneumococcal Vaccination Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pneumococcal Vaccination Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of PPSV 23
Figure 10. Product Picture of PCV 7/13
Figure 11. Product Picture of PCV 10
Figure 12. Global Pneumococcal Vaccination Sales Market Share by Type in 2022
Figure 13. Global Pneumococcal Vaccination Revenue Market Share by Type (2018-2023)
Figure 14. Pneumococcal Vaccination Consumed in Child
Figure 15. Global Pneumococcal Vaccination Market: Child (2018-2023) & (Units)
Figure 16. Pneumococcal Vaccination Consumed in Adult
Figure 17. Global Pneumococcal Vaccination Market: Adult (2018-2023) & (Units)
Figure 18. Global Pneumococcal Vaccination Sales Market Share by Application (2022)
Figure 19. Global Pneumococcal Vaccination Revenue Market Share by Application in 2022
Figure 20. Pneumococcal Vaccination Sales Market by Company in 2022 (Units)
Figure 21. Global Pneumococcal Vaccination Sales Market Share by Company in 2022
Figure 22. Pneumococcal Vaccination Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Pneumococcal Vaccination Revenue Market Share by Company in 2022
Figure 24. Global Pneumococcal Vaccination Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Pneumococcal Vaccination Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Pneumococcal Vaccination Sales 2018-2023 (Units)
Figure 27. Americas Pneumococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 28. APAC Pneumococcal Vaccination Sales 2018-2023 (Units)
Figure 29. APAC Pneumococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 30. Europe Pneumococcal Vaccination Sales 2018-2023 (Units)
Figure 31. Europe Pneumococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Pneumococcal Vaccination Sales 2018-2023 (Units)
Figure 33. Middle East & Africa Pneumococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 34. Americas Pneumococcal Vaccination Sales Market Share by Country in 2022
Figure 35. Americas Pneumococcal Vaccination Revenue Market Share by Country in 2022
Figure 36. Americas Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 37. Americas Pneumococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 38. United States Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Pneumococcal Vaccination Sales Market Share by Region in 2022
Figure 43. APAC Pneumococcal Vaccination Revenue Market Share by Regions in 2022
Figure 44. APAC Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 45. APAC Pneumococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 46. China Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Pneumococcal Vaccination Sales Market Share by Country in 2022
Figure 54. Europe Pneumococcal Vaccination Revenue Market Share by Country in 2022
Figure 55. Europe Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 56. Europe Pneumococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 57. Germany Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Pneumococcal Vaccination Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 66. Egypt Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Pneumococcal Vaccination in 2022
Figure 72. Manufacturing Process Analysis of Pneumococcal Vaccination
Figure 73. Industry Chain Structure of Pneumococcal Vaccination
Figure 74. Channels of Distribution
Figure 75. Global Pneumococcal Vaccination Sales Market Forecast by Region (2024-2029)
Figure 76. Global Pneumococcal Vaccination Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Pneumococcal Vaccination Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Pneumococcal Vaccination Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Pneumococcal Vaccination Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Pneumococcal Vaccination Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pneumococcal Vaccination
Figure 2. Pneumococcal Vaccination Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pneumococcal Vaccination Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Pneumococcal Vaccination Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pneumococcal Vaccination Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of PPSV 23
Figure 10. Product Picture of PCV 7/13
Figure 11. Product Picture of PCV 10
Figure 12. Global Pneumococcal Vaccination Sales Market Share by Type in 2022
Figure 13. Global Pneumococcal Vaccination Revenue Market Share by Type (2018-2023)
Figure 14. Pneumococcal Vaccination Consumed in Child
Figure 15. Global Pneumococcal Vaccination Market: Child (2018-2023) & (Units)
Figure 16. Pneumococcal Vaccination Consumed in Adult
Figure 17. Global Pneumococcal Vaccination Market: Adult (2018-2023) & (Units)
Figure 18. Global Pneumococcal Vaccination Sales Market Share by Application (2022)
Figure 19. Global Pneumococcal Vaccination Revenue Market Share by Application in 2022
Figure 20. Pneumococcal Vaccination Sales Market by Company in 2022 (Units)
Figure 21. Global Pneumococcal Vaccination Sales Market Share by Company in 2022
Figure 22. Pneumococcal Vaccination Revenue Market by Company in 2022 ($ Million)
Figure 23. Global Pneumococcal Vaccination Revenue Market Share by Company in 2022
Figure 24. Global Pneumococcal Vaccination Sales Market Share by Geographic Region (2018-2023)
Figure 25. Global Pneumococcal Vaccination Revenue Market Share by Geographic Region in 2022
Figure 26. Americas Pneumococcal Vaccination Sales 2018-2023 (Units)
Figure 27. Americas Pneumococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 28. APAC Pneumococcal Vaccination Sales 2018-2023 (Units)
Figure 29. APAC Pneumococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 30. Europe Pneumococcal Vaccination Sales 2018-2023 (Units)
Figure 31. Europe Pneumococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 32. Middle East & Africa Pneumococcal Vaccination Sales 2018-2023 (Units)
Figure 33. Middle East & Africa Pneumococcal Vaccination Revenue 2018-2023 ($ Millions)
Figure 34. Americas Pneumococcal Vaccination Sales Market Share by Country in 2022
Figure 35. Americas Pneumococcal Vaccination Revenue Market Share by Country in 2022
Figure 36. Americas Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 37. Americas Pneumococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 38. United States Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 39. Canada Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 40. Mexico Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 41. Brazil Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 42. APAC Pneumococcal Vaccination Sales Market Share by Region in 2022
Figure 43. APAC Pneumococcal Vaccination Revenue Market Share by Regions in 2022
Figure 44. APAC Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 45. APAC Pneumococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 46. China Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 47. Japan Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 48. South Korea Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 49. Southeast Asia Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 50. India Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 51. Australia Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 52. China Taiwan Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 53. Europe Pneumococcal Vaccination Sales Market Share by Country in 2022
Figure 54. Europe Pneumococcal Vaccination Revenue Market Share by Country in 2022
Figure 55. Europe Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 56. Europe Pneumococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 57. Germany Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 58. France Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 59. UK Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 60. Italy Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 61. Russia Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 62. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Country in 2022
Figure 63. Middle East & Africa Pneumococcal Vaccination Revenue Market Share by Country in 2022
Figure 64. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Type (2018-2023)
Figure 65. Middle East & Africa Pneumococcal Vaccination Sales Market Share by Application (2018-2023)
Figure 66. Egypt Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 67. South Africa Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 68. Israel Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 69. Turkey Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 70. GCC Country Pneumococcal Vaccination Revenue Growth 2018-2023 ($ Millions)
Figure 71. Manufacturing Cost Structure Analysis of Pneumococcal Vaccination in 2022
Figure 72. Manufacturing Process Analysis of Pneumococcal Vaccination
Figure 73. Industry Chain Structure of Pneumococcal Vaccination
Figure 74. Channels of Distribution
Figure 75. Global Pneumococcal Vaccination Sales Market Forecast by Region (2024-2029)
Figure 76. Global Pneumococcal Vaccination Revenue Market Share Forecast by Region (2024-2029)
Figure 77. Global Pneumococcal Vaccination Sales Market Share Forecast by Type (2024-2029)
Figure 78. Global Pneumococcal Vaccination Revenue Market Share Forecast by Type (2024-2029)
Figure 79. Global Pneumococcal Vaccination Sales Market Share Forecast by Application (2024-2029)
Figure 80. Global Pneumococcal Vaccination Revenue Market Share Forecast by Application (2024-2029)
